Éternelle is a forward-thinking organization focused on advanced DNA Sequencing, Genomics, Research, Longevity and Next-Generation Natural & Organic Supplements. Éternelle’s assets include a disruptive, state-of-the-art, low-cost, DNA sequencing laboratory; a modern, indoor licensed facility; and partnerships with leaders in supplement manufacturing, DNA data sequencing, logistics and consumer packaged goods. Éternelle is developing high-quality formulations and manufacturing capabilities for its own proprietary products, as well as positioning itself to contract manufacture products for consumer-packaged-goods brands. Éternelle’s management team has significant supplementation and DNA sequencing experience and is led by a CEO that has deep knowledge and understanding of health-related marketing practices as well as supplement manufacturing and deployment on an international scale.